Hydrocortisone Sodium Succinate — Drug Intelligence | 4 EU Trials

Filter these 4 trials by condition, phase, country and more.

4 Registered trials

2 Recruiting

1 Completed trials

4 Sponsors

19 Countries

Phase III

Phase II/III

Phase I/II

Phase III: 2 Phase II/III: 1 Phase I/II: 1

Oversight events:

3 serious breaches across 1 trial

Indications tested

4 total

PHASE IB/II STUDY TO EVALUATE SAFETY AND PRELIMINARY EFFICACY OF ZANIDATAMAB IN COMBINATION WITH TUCATINIB AND CHEMOTHERAPY (CAPECITABINE OR… Pending

2025-524613-89-00 Phase I/II 1 country Medica Scientia Innovation Research S.L.
RECOVERY Recruiting

2023-507441-29-00 Phase III 9 countries University Of Oxford
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting

2022-501050-11-01 Phase II/III 14 countries Karolinska University Hospital
International trial in Philadelphia chromosome-positive acute lymphoblastic leukemia Ended

2024-515499-12-00 Phase III 12 countries Universita Degli Studi Di Milano Bicocca

Showing 1–4 of 4 trials